Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
A plain language summary of the preliminary results for encorafenib plus binimetinib and pembrolizumab in adults with BRAF V600-mutant melanoma in the STARBOARD study.
Journal: Future oncology (London, England)
Published: May 07, 2025
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.
Journal: Future oncology (London, England)
Published: January 11, 2025
Oral microbiome and mycobiome dynamics in cancer therapy-induced oral mucositis.
Journal: Scientific data
Published: October 15, 2024
First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 12, 2024
Letter to the Editor: ETV6-NTRK2 Fusion Identified in a Patient with Medullary Thyroid Carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 24, 2023
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma.
Journal: Future oncology (London, England)
Published: March 11, 2022
Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: May 12, 2015
Breast Cancer in Elderly Caucasian Women-An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival.
Journal: Cancers
Published: April 19, 2015
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.
Journal: The breast journal
Published: January 21, 2015
Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
Journal: The breast journal
Published: December 18, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026